1271 related articles for article (PubMed ID: 18635320)
1. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer.
Caudell JJ; Schaner PE; Meredith RF; Locher JL; Nabell LM; Carroll WR; Magnuson JS; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):410-5. PubMed ID: 18635320
[TBL] [Abstract][Full Text] [Related]
2. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for severe Dysphagia after concurrent chemoradiotherapy for head and neck cancers.
Koiwai K; Shikama N; Sasaki S; Shinoda A; Kadoya M
Jpn J Clin Oncol; 2009 Jul; 39(7):413-7. PubMed ID: 19383615
[TBL] [Abstract][Full Text] [Related]
4. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence.
Nguyen NP; Frank C; Moltz CC; Vos P; Smith HJ; Bhamidipati PV; Karlsson U; Nguyen PD; Alfieri A; Nguyen LM; Lemanski C; Chan W; Rose S; Sallah S
Radiother Oncol; 2006 Sep; 80(3):302-6. PubMed ID: 16890314
[TBL] [Abstract][Full Text] [Related]
5. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
6. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
9. Impact of dysphagia on quality of life after treatment of head-and-neck cancer.
Nguyen NP; Frank C; Moltz CC; Vos P; Smith HJ; Karlsson U; Dutta S; Midyett A; Barloon J; Sallah S
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):772-8. PubMed ID: 15708256
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer.
Prosnitz RG; Yao B; Farrell CL; Clough R; Brizel DM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1087-95. PubMed ID: 15752888
[TBL] [Abstract][Full Text] [Related]
11. Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer.
Franzmann EJ; Lundy DS; Abitbol AA; Goodwin WJ
Head Neck; 2006 Aug; 28(8):663-70. PubMed ID: 16783832
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
Chen AM; Li BQ; Lau DH; Farwell DG; Luu Q; Stuart K; Newman K; Purdy JA; Vijayakumar S
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1026-32. PubMed ID: 20231073
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
Finnegan V; Parsons JT; Greene BD; Sharma V
Head Neck; 2009 Feb; 31(2):167-74. PubMed ID: 18853443
[TBL] [Abstract][Full Text] [Related]
14. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Mancuso AA
Head Neck; 2003 Jul; 25(7):535-42. PubMed ID: 12808656
[TBL] [Abstract][Full Text] [Related]
15. Late esophageal toxicity after radiation therapy for head and neck cancer.
Chen AM; Li BQ; Jennelle RL; Lau DH; Yang CC; Courquin J; Vijayakumar S; Purdy JA
Head Neck; 2010 Feb; 32(2):178-83. PubMed ID: 19536858
[TBL] [Abstract][Full Text] [Related]
16. Dysphagia after sequential chemoradiation therapy for advanced head and neck cancer.
Goguen LA; Posner MR; Norris CM; Tishler RB; Wirth LJ; Annino DJ; Gagne A; Sullivan CA; Sammartino DE; Haddad RI
Otolaryngol Head Neck Surg; 2006 Jun; 134(6):916-22. PubMed ID: 16730530
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
Feng FY; Kim HM; Lyden TH; Haxer MJ; Feng M; Worden FP; Chepeha DB; Eisbruch A
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1289-98. PubMed ID: 17560051
[TBL] [Abstract][Full Text] [Related]
18. Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation.
Nguyen NP; North D; Smith HJ; Dutta S; Alfieri A; Karlsson U; Lee H; Martinez T; Lemanski C; Nguyen LM; Ludin A; Sallah S
Surg Oncol; 2006 Dec; 15(4):199-203. PubMed ID: 17280829
[TBL] [Abstract][Full Text] [Related]
19. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic management of upper esophageal strictures after treatment of head and neck malignancy.
Ahlawat SK; Al-Kawas FH
Gastrointest Endosc; 2008 Jul; 68(1):19-24. PubMed ID: 18355822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]